We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.
XOLAIR omalizumab (rch) 75 mg solution for injection pre-filled pen (2024-25)
Product name
XOLAIR omalizumab (rch) 75 mg solution for injection pre-filled pen
Sponsor name
Novartis Pharmaceuticals Australia Pty Ltd
Year Range
2024-25